ArticlePDF Available

A Case of Severe Tricuspid Stenosis of Rheumatic Origin

Authors:
  • NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES, DHAKA

Abstract and Figures

Tricuspid valve stenosis is a valvular heart disease which results in the narrowing of the orifice of the tricuspid valve of the heart. It’s relatively a rare condition. It is almost always caused by rheumatic fever and is generally accompanied by mitral stenosis.Other rare causes include carcinoid syndrome, endocarditis, endomyocardial fibrosis, lupus erythematosus, right atrial myxoma and congenital tricuspid atresia. Here we describe a patient with history of prior CMC presented with severe Tricuspid Stenosis with Tricuspid Regurgitation (Grade-IV), Mitral Restenosis (Severe), Mitral Regurgitation (grade-1+), Aortic Stenosis (Mild) and Aortic Regurgitation (Grade-2). Keywords: Tricuspid stenosis; Rheumatic heart disease; Valvular heart disease. DOI: http://dx.doi.org/10.3329/cardio.v3i2.9197 Cardiovasc. J. 2011; 3(2): 235-238
Content may be subject to copyright.
235 Vol.-3, No.-2, January 2011 Cardiovas Journal
Introduction:
Tricuspid valve stenosis is a valvular heart disease
which results in the narrowing of the orifice of the
tricuspid valve of the heart. It’s relatively a rare
condition. The stenosis causes increased resistance
to blood flow through the valve. It is almost always
caused by rheumatic fever and is generally
accompanied by mitral stenosis.Rare other causes
include carcinoid syndrome, endocarditis,
endomyocardial fibrosis, lupus erythematosus,
right atrial myxoma and congenital tricuspid
atresia.1-9
The mortality associated with tricuspid stenosis
depends on the precipitating cause. The general
mortality rate is approximately 5%.1
Tricuspid stenosis is found in approximately 3% of
the international population. It is more prevalent
in areas with a high incidence of rheumatic fever.
The congenital form of the disease is rare and true
incidence is not available.1,2
Tricuspid stenosis can present as a congenital
lesion or later in life when it is due to some other
condition. The congenital form accounts for
approximately 0.3% of all congenital heart disease
cases. The frequency of tricuspid stenosis in the
older population, due to secondary causes, ranges
from 0.3-3.2%.2
Tricuspid stenosis is observed more commonly in
women than in men, similar to mitral stenosis of
rheumatic origin. The congenital form of the
disease has a slightly higher male predominance.2
Tricuspid valve stenosis itself usually doesn’t
require treatment. However, if there is damage
to other valves in the heart as well, then surgical
repair or replacement must be considered.The
treatment is usually by surgery (tricuspid valve
replacement) or percutaneous balloon
valvuloplasty. The resultant tricuspid regurgitation
from percutaneous treatment is better tolerated
than insufficiency occurring during mitral
valvuloplasty.1-3
Here we describe a patient with history of prior
Closed Mitral Commissurotomy (CMC) presented
with severe Tricuspid Stenosis with Tricuspid
Regurgitation (Grade-IV), Mitral Restenosis
(Severe), Mitral Regurgitation (Grade-1+), Aortic
Stenosis (Mild) and Aortic Regurgitation (Grade-2).
Case History:
Mrs. X , a 34 years old housewife, admitted into
NICVD, with the complaints of exertional
shortness of breath for last 11 years and shortness
of breath on lying flat for last 2 years. She also
complained of recurrent swelling of both lower
limbs and distension of abdomen that was
occasionally relieved by intravenous diuretics. She
was diagnosed as a case of chronic rheumatic heart
disease with severe mitral stenosis and underwent
CMC in 1993 when he was only 15 years old. After
A Case of Severe Tricuspid Stenosis of
Rheumatic Origin
MT Rahman, M Das, M Ullah, Z Rahman, A Hossain, LA Sayami, SS Roy, AAS Majumder
Department of Cardiology, National Institute of Cardiovascular Disease, Dhaka, Bangladesh.
Abstract:
Tricuspid valve stenosis is a valvular heart disease which results in the narrowing of the orifice of
the tricuspid valve of the heart. It’s relatively a rare condition. It is almost always caused by
rheumatic fever and is generally accompanied by mitral stenosis.Other rare causes include carcinoid
syndrome, endocarditis, endomyocardial fibrosis, lupus erythematosus, right atrial myxoma and
congenital tricuspid atresia. Here we describe a patient with history of prior CMC presented with
severe Tricuspid Stenosis with Tricuspid Regurgitation (Grade-IV), Mitral Restenosis (Severe),
Mitral Regurgitation (grade-1+), Aortic Stenosis (Mild) and Aortic Regurgitation (Grade-2).
(Cardiovasc. j. 2011; 3(2): 235-238)
Address of Correspondence- Dr. Md. Toufiqur Rahman , Associate Professor, Department of Cardiology , NICVD,
Dhaka, Bangladesh.
Keywords:
Tricuspid
stenosis;
Rheumatic heart
disease; Valvular
heart disease.
236 Vol.-3, No.-2, January 2011 Cardiovas Journal
doing CMC she was reasonably well for the next 8
years.
On examination, patient was ill looking,
orthopnoeic, mildly anaemic, edematous, mildly
icteric, not cyanosed. Her neck vein was engorged.
Pulse rate was 80 b/min, irregularly irregular with
pulsus deficit of 16 beats/ min. B.P. was 80/60
mmHg. Apex is shifted 2 cm lateral to left
midclavicular line and left parasternal heave was
present. First heart sound was variable, P2 was
palpable. There was a mid diastolic murmur ,
grade-3/6 over apical area and a ejection systolic
murmur over right second intercostal space and
a diastolic murmur over left lower sternal border
having grade of 3/6. Breath sound was vesicular
and there was bilateral basal crepitations. There
was tense ascites and tender hepatomegaly. On
careful Echo Doppler examination, patient had
Tricuspid Stenosis (Severe) with Tricuspid
Regurgitation (Grade-IV), Mitral Stenosis (Severe),
Mitral Regurgitation (grade-1+), Aortic Stenosis
(Mild) and Aortic Regurgitation (Grade-2) (Fig-
1,2,3). She was treated conservatively.
Discussion:
Tricuspid valve dysfunction can result from
morphological alterations in the valve or from
functional aberrations of the myocardium.
Tricuspid stenosis is almost always rheumatic in
origin and is generally accompanied by mitral and
aortic valve involvement.1
Most stenotic tricuspid valves are associated with
clinical evidence of regurgitation that can be
documented by performing a physical examination
(murmur), echocardiography, or angiography.
Stenotic tricuspid valves are always anatomically
abnormal, and the cause is limited to a few
conditions. With the exceptions of congenital
causes or active infective endocarditis, tricuspid
stenosis takes years to develop.2,3
Sato M et al described a case of tricuspid stenosis
found intraoperatively during aortic valve
replacement and open mitral commissurotomy
with congestive heart failure due to mitral
regurgitation and tricuspid regurgitation and so,
commissurotomy and modified Kay’s annuloplasty
was tried but failed to decrease the central
regurgitation. A CarboMedics 23 mm prosthesis
was implanted in the mitral position and a
Capentier-Edwards 29 mm in the tricuspid
position.10
Tsutomu Saito 11 et al reported the case of a 42-
year-old man in whom dyspnea on exertion was
found to be caused by isolated tricuspid stenosis.
Two-dimensional echocardiogram showed
thickening of the tricuspid valve with a markedly
enlarged right atrium. A color-flow Doppler
examination-revealed severe tricuspid stenosis
without regurgitation and a Doppler-derived
Fig.-1: Mitral stenosis
Fig.-2: Aortic regurgitation
Fig.-3: Tricuspid Stenosis
A Case of Severe Tricuspid Stenosis of Rheumatic Origin MT Rahman et al.
236
237 Vol.-3, No.-2, January 2011 Cardiovas Journal
tricuspid diastolic pressure gradient of 23 mmHg.
At the time of surgery, the patient was noted to
have a stenotic tricuspid valve with thickened
leaflets, fused commissures, and almost normal
chorda tendineae. The valve leaflets were teased
apart to the scattered specimen, and tricuspid
valve replacement was successfully performed.
Microscopic examination of the specimen
demonstrated infective endocarditis. Isolated
acquired tricuspid stenosis is extremely rare and
that was the first case of infective endocarditis
being involved as the primary cause.
Yash Y et al reported a patient with congenital
tricuspid stenosis successfully treated by
percutaneous balloon valvotomy that appears to
be an alternative to surgery when the anatomy,
as demonstrated by echocardiography, is
suitable.12
Taira Kayano et al13 reported Tricuspid Valve
Stenosis Related to Subvalvular Adhesion of
Pacemaker Lead An excessive loop of a ventricular
lead, especially a subvalvular loop, can cause
opening limitation of the tricuspid valve, and the
entangling of the lead in the subvalvular structures
can easily induce reactive fibrosis and adhesions.
Hussain et al described a case tricuspid stenosis
in a young woman 11 years after endocardial
ventricular lead implantation. The cause of the
stenosis was perforation of the septal leaflet by
the lead at the time of insertion and then successful
management with percutaneous balloon
valvuloplasty without the need for lead removal.14
Ashraf et al reported a case of concurrent
successful percutaneous valvuloplasty of combined
mitral and tricuspid value stenosis employing the
Inoue technique.15 D J Heaven et al16 described
two cases of pacemaker lead related tricuspid
stenosis. Sivert Svane reported six autopsied cases
of Congenital Tricuspid Stenosis17 .M E Lee et al
reported a case of unusual complications of
endocardial pacing like simultaneous thrombosis
of the superior and inferior venae cavae and
supravalvular, valvular, and infravalvular stenosis
of the tricuspid valve.18 L G Van der Hauwaert et
al 19 reported a case of fibroma of the right
ventricle producing severe tricuspid stenosis.
Roguin et al20 reported Long-term follow-up of
patients with severe rheumatic tricuspid stenosis.
13 patients (11 women and 2 men) with severe
tricuspid stenosis who were followed closely for 6
to 31 years. The mean tricuspid pressure gradient
ranged from 3 to 9 mm Hg. Twelve patients
underwent surgery for mitral and/or aortic valve
lesions without complications. Concomitant
tricuspid valve surgery was performed on six
patients. After successful repair of the mitral or
aortic valve, and regardless of the type of tricuspid
valve surgery, severe tricuspid stenosis was found
to be very well tolerated by all the patients over
many years of follow-up. L V Basso et al reported
a case of Tricuspid valve obstruction due to
intravenous leiomyomatosis.21
References:
1. Waller BF. Morphological aspects of valvular heart
disease: Part I. Curr Probl Cardiol 1984;9(7):1-66.
2. Waller BF. Morphological aspects of valvular heart
disease: Part II. Curr Probl Cardiol 1984;9(8):1-74.
3. Morgan JR, Forker AD, Coates JR, Myers WS. Isolated
tricuspid stenosis. Circulation 1971;44(4):729-32.
4. Mukhopadhyay S, Suryavanshi S, Yusuf J, et al. Isolated
thrombus producing tricuspid stenosis: an unusual
presentation in primary antiphospholipid syndrome.
Indian Heart J 2004;56(1):61-3.
5. Sakata Y, Koibuchi N, Xiang F, et al. The spectrum of
cardiovascular anomalies in CHF1/Hey2 deficient mice
reveals roles in endocardial cushion, myocardial and
vascular maturation. J Mol Cell Cardiol 2005; 18.
6. Sharieff S, Saghir T, Shah-e-Zaman K, et al. Concurrent
percutaneous valvuloplasty of mitral and tricuspid valve
stenoses. J Invasive Cardiol 2005;17(6):340-2.
7. DiSesa VJ, Mills RM Jr, Collins JJ Jr. Surgical
management of carcinoid heart disease. Chest
1985;88(5):789-91.
8. Kratz JM, Crawford FA Jr, Stroud MR, et al. Trends
and results in tricuspid valve surgery. Chest
1985;88(6):837-40.
9. Miller BR, Vohr FH, Christian FV, Singh AK. Cardiac
valvular replacement in carcinoid heart disease. Am J
Med 1983;75(5):896-8.
10. Sato M, Ito J, Hayashibe Y, Goto K, Maemura T, Konno
S, Sekiya T. A case report of tricuspid replacement for
the acquired tricuspid stenosis at the time of
reoperation. Kyobu Geka 1994 ;47(5):398-400.
11. Tsutomu Saito, Hiroyuki Horimi, Tsuguo Hasegawa ,
Toshiro Kamoshida. Isolated tricuspid valve stenosis
caused by infective endocarditis in an adult: Report of a
case. Surgery Today 1993; 23(12):1081-1084.
12. Yash Y. Lokhandwala , Rajesh M. Rajani, Bharat V.
Dalvi and Purshottam A. Successful balloon valvotomy
in isolated congenital tricuspid stenosis . CardioVascular
and Interventional Radiology, Springer New York 1990;
13( 6):354-356.
Cardiovascular Journal Volume 3, No. 2, 2011
237
238 Vol.-3, No.-2, January 2011 Cardiovas Journal
13. Taira Kayano,Suzuki Asumi, Fujino Akihisa ,
Watanabe Tatsuya , Ogyu Atsuhiro, Ashikawa
Kouichi .Tricuspid Valve Stenosis Related to Subvalvular
Adhesion of Pacemaker Lead: A Case Report. J Cardiol
2006; .47(6):301-306.
14. Tarique Hussain, William Brodie Knight and Karen A.
McLeod, Lead-Induced Tricuspid Stenosis—Successful
Management by Balloon Angioplasty. Pacing and
Clinical Electrophysiology 2009;32,(1), 140-142.
15. Tariq Ashraf, Asad Pathan, Asadullah Kundi.
Percutaneous Balloon Valvuloplasty of Coexisting Mitral
and Tricuspid Stenosis: Single-Wire, Double-Balloon
Technique. J Invasive Cardiol 2008;20:E126-E128.
16. D J Heaven, M Y Henein, R Sutton. Pacemaker lead
related tricuspid stenosis: a report of two cases. Am
Heart J 1998 ;136 (1):103-8.
17. Sivert Svane. Congenital Tricuspid Stenosis:A Report
on Six Autopsied Cases Scandinavian Cardiovascular
Journal 1971;5(3): 232-238.
18. M E Lee, A Chaux Unusual complications of endocardial
pacing. Clin Cardiol 1995 ;18 (3):167-74.
19. L G Van der Hauwaert, L Corbeel, P Maldague Fibroma
of the right ventricle producing severe tricuspid stenosis.
Heart 2000 ;83 (3):351-2.
20. A Roguin, D Rinkevich, S Milo, W Markiewicz, S A
Reisner Long-term follow-up of patients with severe
rheumatic tricuspid stenosis. Am Heart J 1998 ;136
(1):103-8.
21. L V Basso, M Gradman, S Finkelstein, L Gonzalez-
Lavin Tricuspid valve obstruction due to intravenous
leiomyomatosis. Curr Probl Cardiol 1984 ;9 (8):1-74.
A Case of Severe Tricuspid Stenosis of Rheumatic Origin MT Rahman et al.
238
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Forty-six tricuspid valve operations were performed over 12 years. Operations were conservative (two valvotomies, eight DeVega annuloplasties, seven Carpentier rings) in 17 and valve replacement (17 mechanicals, 12 tissues) in 29. Operative mortality rate was improved with better preoperative functional class, use of cardioplegia, or use of annuloplasty. Heart block occurred less with annuloplasty (6 vs 24 percent). Long-term survival was similar with annuloplasty or porcine valve replacement, but was poorer with mechanical valve replacement. Four of eight DeVega annuloplasties failed during the operative (two) or late (two) period. When the anatomy is suitable, we believe the Carpentier ring annuloplasty to be safe and effective. When valve replacement cannot be avoided, we believe replacement with a tissue valve is preferable.
Article
This report concerns two unusual complications of endocardial pacing: (1) simultaneous thrombosis of the superior and inferior venae cavae and (2) supravalvular, valvular, and infravalvular stenosis of the tricuspid valve. The management of both cases required removal of all endocardial leads with the aid of cardiopulmonary bypass, with inferior vena cava thrombectomy in the first case and tricuspid valve replacement in the second. From our review of the literature, we have reached the following conclusions: (1) Clinical thrombosis secondary to endocardial pacing leads is rare (1.2%), but venography in asymptomatic patients revealed venous thrombosis in 44% of the patients studied. (2) Endocardial pacing leads should have the smallest outer diameter possible, preferably with an electro-negative, thromboresistant surface, and should be implanted with minimal redundancy. The risk of venous thrombosis should be kept in mind when recommending atrioventricular sequential pacing systems requiring multiple leads passing through the superior vena cava. (3) Retained leads which are infected or have migrated and become redundant or looped are at risk of causing septicemia, thrombosis, or septic embolization and should be removed. The high incidence of subclinical venous thrombosis suggests that reasonable efforts be made to remove all retained leads.
Article
We describe a case of tricuspid stenosis in a young woman 11 years after endocardial ventricular lead implantation. The cause of the stenosis appears to have been perforation of the septal leaflet by the lead at the time of insertion. We further describe successful management with percutaneous balloon valvuloplasty without the need for lead removal.
Article
Isolated congenital tricuspid valve stenosis is a rare entity. The modalities of definitive treatment have been surgical repair or replacement. We present the first reported patient with congenital tricuspid stenosis successfully treated by percutaneous balloon valvotomy. This appears to be an alternative to surgery when the anatomy, as demonstrated by echocardiography, is suitable.
Article
Two female patients with carcinoid heart disease, ages 56 and 32 years, underwent pulmonic valve resection surgery and tricuspid valve replacement with a porcine bioprosthesis. Preoperatively, both patients were in function class 4 with severe right-side congestive failure and signs of tricuspid regurgitation and pulmonic stenosis. Both underwent surgery for porcine tricuspid valve replacement (33 and 31 mm valves) and pulmonic valve resection. Postoperatively, both patients had only minimal symptoms, including trace ankle edema and soft pulmonic murmurs, despite persistence of the systemic symptoms of carcinoid syndrome. Pre- and postoperative catheterization data documented hemodynamic improvements. One patient eventually died of hepatic failure due to metastatic disease. At autopsy, her bioprosthesis was free of carcinoid valvular changes.
Article
A case is reported of isolated tricuspid stenosis with a 5-year hemodynamic follow-up after a tricuspid commissurotomy. Fusion of the commissures and chordae tendineae of the tricuspid valve was noted at surgery. There was a history of rheumatic fever, and 5 years after surgery mild mitral stenosis had developed. Seven previously reported cases of isolated tricuspid stenosis have been considered by some authors to be congenital in origin, and, therefore, isolated tricuspid stenosis of rheumatic origin is thought to be established for the first time.
Article
Among 394 necropsied cases with all kinds of congenital cardiac anomalies, 7 cases were tricuspid atresias which are reviewed in a separate paper. Five cases were registered as congenital tricuspid stenoses. These cases, together with an additional sixth case, are discussed in the present paper, mainly taking the anatomical findings into consideration. They represent an indistinct and rather heterogeneous group within the field of cardiac anomalies, which is not generally accepted. In the opinion of the author, this group cannot be omitted in a general survey on congenital heart diseases. It is necessary, however, to distinguish between a rather distinct valvular and a more questionable annular stenosis. In the former, the cusps are fused together forming a membrane with varying aperture. Three of the present cases belong to this type, and one of them is classified as isolated (pure) congenital tricuspid stenosis. The annular stenosis is mainly characterized by a narrow valve ring, and is usually associated with pulmonary stenosis or atresia including a small right ventricle. The true nature and the functional importance of the annular tricuspid stenosis is, in the opinion of the author, still an unsolved problem which deserves further investigation.
Article
A case of fibroma of the right ventricle in a child of 16 months is reported. The clinical and hemodynamic findings were those of severe tricuspid stenosis. Angiocardiography proved the obstruction to be due to a cardiac neoplasm, localized within the right ventricle. An attempt at surgical removal failed because the tumor, almost completely filling the cavity of the right ventricle, was too extensive and could not be distinctly delineated from the healthy myocardium.